🇺🇸 FDA
Pipeline program

TQH2722 injection

TQH2722-II-06

Phase 2 small_molecule active

Quick answer

TQH2722 injection for Seasonal Allergic Rhinitis is a Phase 2 program (small_molecule) at Shanghai University of Traditional Chinese Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Shanghai University of Traditional Chinese Medicine
Indication
Seasonal Allergic Rhinitis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials